首页> 外文期刊>JAMA: the Journal of the American Medical Association >Altitude and all-cause mortality in incident dialysis patients.
【24h】

Altitude and all-cause mortality in incident dialysis patients.

机译:透析患者的海拔高度和全因死亡率。

获取原文
获取原文并翻译 | 示例
       

摘要

CONTEXT: Patients undergoing dialysis at higher altitude receive lower erythropoietin doses, yet achieve higher hemoglobin concentrations. Increased iron availability caused by activation of hypoxia-induced factors at higher altitude may explain this finding. Hypoxia-induced factors are also involved in other pathways that may affect morbidity and mortality. OBJECTIVE: To study whether mortality differed by altitude in patients initiating dialysis. DESIGN, SETTING, AND PARTICIPANTS: Retrospective cohort of patients initiating dialysis in the United States between 1995 and 2004. Patients were stratified by the average elevation of their residential zip code. Covariates included age, sex, race, Medicaid coverage, dialysis modality, comorbidities, and reported laboratory measurements. We constructed proportional hazards models of all-cause mortality, stratifying by year, and censoring patients at 5 years from first dialysis, at the end of the database (December 31, 2004), or loss to follow-up. We also compared age- and sex-adjusted standardized mortality rates of US patients receiving dialysis with the general population. MAIN OUTCOME MEASURE: Mortality from any cause. RESULTS: A total of 804 812 patients initiated dialysis and were followed up for a median of 1.78 years. Crude mortality rates per 1000 person-years were 220.1 at an altitude lower than 76 m (<250 ft), 221.2 from 76 through 609 m (250-1999 ft), 214.6 from 610 through 1218 m (2000-3999 ft), 184.9 from 1219 through 1828 m (4000 to 5999 ft), and 177.2 at an altitude higher than 1828 m (>6000 ft). After multivariable adjustment, compared with patients living at an altitude of lower than 76 m, the relative mortality rates were 0.97 (95% confidence interval [CI], 0.96-0.98) for those living from 76 through 609 m; 0.93 (95% CI, 0.91-0.95), from 610 through 1218 m; 0.88 (95% CI, 0.84-0.91), from 1219 through 1828 m, and 0.85 (95% CI, 0.79-0.92) higher than 1828 m. Age- and sex-standardized mortality decreased more with altitude in patients receivingdialysis than in the general population. CONCLUSIONS: Altitude was inversely associated with all-cause mortality among US patients receiving dialysis.
机译:背景:在较高的高度进行透析的患者接受的促红细胞生成素剂量较低,但血红蛋白浓度较高。由高海拔地区缺氧诱导的因子激活引起的铁可利用性增加可能解释了这一发现。缺氧诱导的因子也参与其他可能影响发病率和死亡率的途径。目的:研究开始透析的患者死亡率是否因海拔高度而异。设计,地点和参与者:1995年至2004年在美国开始透析的患者的回顾性队列。按居住邮政编码的平均海拔高度对患者进行分层。协变量包括年龄,性别,种族,医疗补助覆盖率,透析方式,合并症和报告的实验室测量值。我们构建了按比例分层的全因死亡率的风险模型,按年份分层,并从数据库的末尾(从2004年12月31日开始)或从首次透析开始的5年内对患者进行审查,或者从丢失到随访。我们还将接受透析的美国患者的年龄和性别校正后的标准化死亡率与普通人群进行了比较。主要观察指标:任何原因造成的死亡率。结果:总共804812例患者开始了透析,平均随访时间为1.78年。海拔低于76 m(<250 ft)时每1000人年的粗死亡率为220.1,76至609 m(250-1999 ft)时为221.2,610至1218 m(2000-3999 ft)时为214.6从1219到1828 m(4000到5999 ft),以及在高于1828 m(> 6000 ft)的高度下为177.2。经过多变量调整后,与生活在海拔低于76 m的患者相比,生活在76至609 m的患者的相对死亡率为0.97(95%置信区间[CI]为0.96-0.98)。从610到1218 m为0.93(95%CI,0.91-0.95);从1219到1828 m为0.88(95%CI,0.84-0.91),比1828 m高0.85(95%CI,0.79-0.92)。接受透析的患者的年龄和性别标准化死亡率降低的程度比一般人群高。结论:海拔高度与接受透析的美国患者的全因死亡率成反比。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号